JPWO2020188288A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2020188288A5
JPWO2020188288A5 JP2022504738A JP2022504738A JPWO2020188288A5 JP WO2020188288 A5 JPWO2020188288 A5 JP WO2020188288A5 JP 2022504738 A JP2022504738 A JP 2022504738A JP 2022504738 A JP2022504738 A JP 2022504738A JP WO2020188288 A5 JPWO2020188288 A5 JP WO2020188288A5
Authority
JP
Japan
Prior art keywords
pain
compound
pharmaceutical composition
composition according
isomer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022504738A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022525706A5 (https=
JP2022525706A (ja
Publication date
Priority claimed from GB1903900.7A external-priority patent/GB2582361A/en
Application filed filed Critical
Publication of JP2022525706A publication Critical patent/JP2022525706A/ja
Publication of JPWO2020188288A5 publication Critical patent/JPWO2020188288A5/ja
Publication of JP2022525706A5 publication Critical patent/JP2022525706A5/ja
Pending legal-status Critical Current

Links

JP2022504738A 2019-03-21 2020-03-19 アデノシン受容体アゴニスト Pending JP2022525706A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB1903900.7A GB2582361A (en) 2019-03-21 2019-03-21 Adenosine receptor agonists
GB1903900.7 2019-03-21
PCT/GB2020/050734 WO2020188288A1 (en) 2019-03-21 2020-03-19 Adenosine receptor agonists

Publications (3)

Publication Number Publication Date
JP2022525706A JP2022525706A (ja) 2022-05-18
JPWO2020188288A5 true JPWO2020188288A5 (https=) 2023-03-27
JP2022525706A5 JP2022525706A5 (https=) 2023-03-27

Family

ID=66381433

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022504738A Pending JP2022525706A (ja) 2019-03-21 2020-03-19 アデノシン受容体アゴニスト

Country Status (5)

Country Link
US (1) US20220152077A1 (https=)
EP (1) EP3941482A1 (https=)
JP (1) JP2022525706A (https=)
GB (1) GB2582361A (https=)
WO (1) WO2020188288A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113082020A (zh) * 2021-04-08 2021-07-09 徐州医科大学 一种腺苷受体激动剂的增强剂及其应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK62692D0 (https=) * 1992-05-14 1992-05-14 Novo Nordisk As
GB9930085D0 (en) * 1999-12-20 2000-02-09 Glaxo Group Ltd Medicaments
GB9930079D0 (en) * 1999-12-20 2000-02-09 Glaxo Group Ltd Medicaments
GB9930075D0 (en) * 1999-12-20 2000-02-09 Glaxo Group Ltd Medicaments
CN103087133B (zh) * 2004-05-26 2016-09-14 伊诺泰克制药公司 嘌呤衍生物作为腺苷a1受体激动剂及其用法
WO2011011919A1 (zh) * 2009-07-31 2011-02-03 新道生技股份有限公司 一种降血糖的组合物
KR20130029049A (ko) * 2010-03-26 2013-03-21 이노텍 파마슈티컬스 코포레이션 아데노신 화합물 및 이의 용도
WO2017137528A1 (en) * 2016-02-12 2017-08-17 Charité - Universitätsmedizin Berlin Adenosine a1 receptor agonist for use in treatment of status epilepticus

Similar Documents

Publication Publication Date Title
JP6089045B2 (ja) 痛みの緩和または治療に使用するためのフェニルカルバメート化合物
JP2013139446A5 (https=)
RU2009124541A (ru) Тозилатная соль терапевтического соединения и ее фармацевтические композиции
CN1235579C (zh) 用于预防或治疗神经变性疾病的氨基甲酸酯化合物
JP2008520589A5 (https=)
JP2010529969A5 (https=)
JP2011525185A5 (https=)
JP2019529460A5 (https=)
JP2014518552A5 (https=)
JP2016537432A5 (https=)
JPWO2020188288A5 (https=)
JPWO2021026180A5 (https=)
JP2006511604A5 (https=)
JP5341037B2 (ja) 双極性障害を処置するための医薬を得るためのアゴメラチンの使用
JP2019535715A5 (https=)
JP2004501079A5 (https=)
JP2021515749A5 (https=)
RU2010122972A (ru) Тозилатная соль транс-n-изобутил-3-фтор-3-[3-фтор-4-(пирролидин-1-илметил)фенил]циклобутанкарбоксамида
JP2011088919A (ja) アゴメラチンとノルアドレナリン再取り込み阻害剤との新たな組み合わせ、及びそれを含有している医薬組成物
JP2004532854A5 (https=)
JP2019535787A5 (https=)
CN113272285B (zh) 含噁二唑的化合物、和含有其的药物组合物
JP2021528479A5 (https=)
RU2019134182A (ru) Новые способы лечения рассеянного склероза
JP2015526447A5 (https=)